Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
75%
OVERLAP
BY WEIGHT
60
# OF OVERLAPPING
HOLDINGS
FHLC
350
HOLDINGS
19%
ALSO IN IXJ
IXJ
114
HOLDINGS
58%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.1% | 10.7% | 10.7% |
|
JOHNSON & JOHNSON | 8.9% | 7.2% | 7.2% |
|
ABBVIE INC | 6.4% | 5.5% | 5.5% |
|
MERCK & CO. INC. | 5.1% | 4.5% | 4.5% |
|
UNITEDHEALTH GROUP INC | 4.7% | 4.2% | 4.2% |
FHLC Overweight Relative to IXJ
|
ELI LILLY & CO | 2.4% |
|
JOHNSON & JOHNSON | 1.7% |
|
ABBVIE INC | 0.9% |
|
NATERA INC | 0.8% |
|
MERCK & CO. INC. | 0.6% |
|
REVOLUTION MEDICINES, INC. | 0.5% |
|
ALNYLAM PHARMACEUTICALS INC | 0.5% |
|
UNITEDHEALTH GROUP INC | 0.5% |
|
THERMO FISHER SCIENTIFIC INC | 0.5% |
|
AMGEN INC | 0.4% |
FHLC Underweight Relative to IXJ
 |
NOVARTIS AG | -3.4% |
 |
ASTRAZENECA PLC | -3.1% |
 |
NOVO NORDISK A/S-B | -1.6% |
|
GSK PLC | -1.2% |
 |
SANOFI-AVENTIS | -1.1% |
 |
CSL LIMITED | -0.8% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |
 |
ARGEN-X SE | -0.7% |
|
HOYA CORP | -0.7% |
 |
BAYER AG | -0.6% |